Search Results - Foeldvari I
- Showing 1 - 3 results of 3
-
1
Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab by Thon A, Tzaribacev N, Kuester R, Kuemmerle-Deschner K, Foeldvari I, Huppertz HI, Fitter S, Horneff G, Borte M, Ganser G, Trauzeddel R, Minden K
Published in Pediatric Rheumatology Online Journal (2011-09-01)Article -
2
2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme... by Ruperto N, Lovell DJ, Cuttica R, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH
Published in Pediatric Rheumatology Online Journal (2008-09-01)Article -
3
JIA affected sibling pairs present high correlation for ANA and ILAR category by Alessio M, Lepore L, Calcagno G, Trauzeddel R, Falcini F, Cortis E, Alpigiani MG, Rumba I, Dressler F, Balogh Z, Zulian F, Pruunsild C, Herlin T, Nielsen S, Stanevicha V, Foeldvari I, Malattia C, Filocamo G, Glass DN, Thompson SD, Martini A, Ruperto N
Published in Pediatric Rheumatology Online Journal (2011-09-01)Article
